Celltech Overview

  • Year Founded
  • 1980

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,900

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 2

Celltech General Information

Description

Provider of biotechnology and pharmaceutical services in United Kingdom. The company is engaged in the research and development of therapies for patients with serious diseases and it focuses on developing treatments for autoimmune and inflammatory disorders and oncology.

Contact Information

Website
www.ucbpharma.co.uk
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 208 Bath Road
  • Slough SL1 3WE
  • England, United Kingdom
Primary Industry
Laboratory Services (Healthcare)
Acquirer
UCB
Vertical(s)
Life Sciences
Corporate Office
  • 208 Bath Road
  • Slough SL1 3WE
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celltech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Celltech‘s full profile, request access.

Request a free trial

Celltech Patents

  • 389

    Total Documents Applications and Grants

  • Total Patents Families

  • 93

    Granted

  • 35

    Pending

  • Expiring in next 12 mo

Celltech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120321608-A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 Inactive 23-Oct-2003
US-20120321636-A1 Antibodies specific for sclerostin and methods for increasing bone mineralization Active 16-Jun-2003
US-20130064829-A1 Antibodies specific for sclerostin and methods for increasing bone mineralization Active 16-Jun-2003
US-8992911-B2 Antibodies specific for sclerostin and methods for increasing bone mineralization Inactive 16-Jun-2003
US-7381409-B2 Immunoglobulin specific to transforming growth factor binding protein for use as tool in prevention and treatment of osteoporosis and bone disorders Active 16-Jun-2003 C07K16/22
To view Celltech’s complete patent history, request access »

Celltech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celltech Acquisitions (2)

Celltech’s most recent deal was a Merger/Acquisition with Oxford Biotherapeutics. The deal was made on 24-Nov-2003.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Oxford Biotherapeutics 24-Nov-2003 Merger/Acquisition Biotechnology
Oxford GlycoSciences 01-Jul-2003 Merger/Acquisition Drug Discovery
To view Celltech’s complete acquisitions history, request access »

Celltech Subsidiaries (1)

Company Name Industry Location Founded
Oxford Biotherapeutics Biotechnology Oxford, United Kingdom
To view Celltech’s complete subsidiaries history, request access »

Celltech FAQs

  • When was Celltech founded?

    Celltech was founded in 1980.

  • Where is Celltech headquartered?

    Celltech is headquartered in Slough, United Kingdom.

  • What is the size of Celltech?

    Celltech has 1,900 total employees.

  • What industry is Celltech in?

    Celltech’s primary industry is Laboratory Services (Healthcare).

  • Is Celltech a private or public company?

    Celltech is a Private company.

  • What is the current valuation of Celltech?

    The current valuation of Celltech is .

  • What is Celltech’s current revenue?

    The current revenue for Celltech is .

  • How much funding has Celltech raised over time?

    Celltech has raised $74.1M.

  • When was Celltech acquired?

    Celltech was acquired on 18-May-2004.

  • Who acquired Celltech?

    Celltech was acquired by UCB.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »